Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time
- PMID: 32032318
- PMCID: PMC8295884
- DOI: 10.1097/OLQ.0000000000001132
Quinolone Resistance-Associated Mutations in Mycoplasma genitalium: Not Ready for Prime Time
Comment on
-
Clearance of Mycoplasma genitalium Infection With Moxifloxacin in the Presence of Quinolone Resistance-Associated Mutations.Sex Transm Dis. 2020 Mar;47(3):197-198. doi: 10.1097/OLQ.0000000000001095. Sex Transm Dis. 2020. PMID: 31738298
References
-
- Antibiotic Resistance Threats in the United States. 2019. Available at https://www.cdc.gov/drugresistance/biggest-threats.html. Accessed January 20, 2019.
-
- Li Y, Le WJ, Li S, et al. Meta-analysis of the efficacy of moxifloxacin in treating Mycoplasma genitalium infection. Int J STD AIDS 2017; 28:1106–1114. - PubMed
-
- Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium–infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis 2015; 60:1228–1236. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
